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A peripheral epigenetic signature of immune
system genes is linked to neocortical thickness
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Increasing age is tightly linked to decreased thickness of the human neocortex. The biological
mechanisms that mediate this effect are hitherto unknown. The DNA methylome, as part of
the epigenome, contributes signiﬁcantly to age-related phenotypic changes. Here, we identify
an epigenetic signature that is associated with cortical thickness (P¼ 3.86 10 8) and
memory performance in 533 healthy young adults. The epigenetic effect on cortical thickness
was replicated in a sample comprising 596 participants with major depressive disorder and
healthy controls. The epigenetic signature mediates partially the effect of age on cortical
thickness (Po0.001). A multilocus genetic score reﬂecting genetic variability of this
signature is associated with memory performance (P¼0.0003) in 3,346 young and elderly
healthy adults. The genomic location of the contributing methylation sites points to the
involvement of speciﬁc immune system genes. The decomposition of blood methylome-wide
patterns bears considerable potential for the study of brain-related traits.
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H
uman cortical thickness, a brain morphometric measure
that is linked to cognitive functioning, reﬂects the amount
of neurons and neuropil in the horizontal layers of
the cortical columns that are responsible for the organization of
cortical connectivity1–3. Recent data suggest a monotonic
decrease in cortical thickness (cortical thinning) from preschool
age throughout the lifespan4, but previous studies have also
described patterns of regional increase in cortical thickness
during childhood5–7.
Studies in twins and in unrelated individuals provide
consistently high heritability estimates for cortical thickness
(B80%), demonstrating the importance of naturally occurring
genetic variation for this physiological trait8,9. Despite the
well-known and substantial impact of age on cortical thinning,
the biological mechanisms that mediate this effect are hitherto
unknown. It is reasonable to assume that age-related, dynamic
processes, such as epigenetic changes, represent good candidates
for such mediators.
DNA methylation, the most extensively studied epigenetic
modiﬁcation to date, regulates important processes such as
imprinting, chromosomal inactivation and gene expression10.
Age represents one of the most potent factors known to correlate
with physiological variation of global DNA methylation11,12.
High-throughput quantiﬁcation of DNA methylation at several
hundreds of thousands of C-phosphate-G (CpG) sites has
detected numerous CpG loci across various tissues undergoing
differential methylation with age13–16. Interestingly, such loci
have been identiﬁed within regulatory regions of genes that are
known to undergo differential expression in such age-related
conditions as Alzheimer’s disease13 and cancer17. Recently, DNA
methylation markers predicting chronological age were shown to
correlate with all-cause mortality18. DNA methylation levels can
also be inﬂuenced by genetic variations19,20 and age-related DNA
methylation signatures represent heritable traits18.
Thus, the existing data suggest that peripherally measured
DNA methylation patterns might contribute to the identiﬁcation
of molecular underpinnings of age-related complex traits relevant
to health and disease.
Here, we investigated the relation between peripherally
measured DNA methylation and cortical thickness in healthy
young adults. In a ﬁrst step, we performed Independent
Component Analysis (ICA)-based decomposition of whole-blood
methylomic proﬁles to identify independent signatures of
physiological variation of global DNA methylation. ICA is
a decomposition method, which provides a representation of
complex relationships arising from high-dimensional data, such
as genome-wide expression21,22 and brain imaging data23. After
ICA-based decomposition, the identiﬁed methylation patterns
were ﬁrst tested for association with age. Age-associated
methylation patterns were subsequently tested for correlation
with global cortical thickness and, in case of such correlation,
mediation analysis followed to assess whether these methylation
patterns mediated signiﬁcantly the effect of age on cortical
thickness. Signiﬁcant ﬁndings were subjected to further analyses,
including functional annotation of CpGs contributing to the
observed methylation patterns, testing for pattern association
with region-speciﬁc cortical thickness and cognitive performance,
and a genome-wide investigation of common genetic variations
(single nucleotide polymorphisms, SNPs) that contribute to the
variability of the methylomic patterns.
Results
ICA-based identiﬁcation of methylomic patterns. We
performed methylomic proﬁling (Illumina 450K Human Methy-
lation array) of blood samples collected from N¼ 533 healthy
young individuals (Supplementary Table 1). After quality control,
DNA methylation levels (DNAm) were quantiﬁed at 397,947
autosomal CpG sites and subsequently corrected for sex
and sources of variation inferred from Surrogate Variable Analysis
(see Methods).
Next, we performed ICA to achieve a low-dimensional
representation of genome-wide methylation proﬁles. Following
the ICA paradigm introduced ﬁrst for gene expression data
analysis21, an individual’s methylomic proﬁle is treated as
a mixture of latent variables (that is, methylomic signatures),
each reﬂecting a combination of biological processes and exerting
independent effects on DNAm. Speciﬁcally, ICA provides
a representation of these signatures by decomposing the
original DNAm signals into components, whose statistical
inter-dependence is minimized. This property is typically
achieved by favouring heavy-tailed non-gaussian distribution of
the components’ loadings; thus each component is characterized
by a restricted set of CpGs exhibiting loadings at the extreme of
the distribution. Simultaneously, each component is characterized
by its representation across the study sample, giving rise
to individual methylation patterns. Each of these patterns is
a low-dimensional representation of a global mode of DNAm
variations. Importantly, these patterns can be tested for
association with traits of the study sample (Fig. 1a).
Using ICA decomposition, we obtained a total of k¼ 126
independent components (see Methods). The majority of the
inferred components (n¼ 111) were driven by single individuals
contributing to more than 10% of the pattern’s variability.
Given that such components represent rather singular modes of
variation24, subsequent analyses were restricted to the remaining
15 components. These components represent global modes of
DNAm variation across the individuals of the study population.
Methylomic patterns related to age and cortical thickness.
Participants from the methylomic proﬁling study underwent
brain magnetic resonance imaging (MRI)(Supplementary
Table 1). Global measures of cortical thickness—that is, the
distance between the grey matter and white-matter boundary and
the pial surface—were obtained using cortical surface-based
analysis implemented in FreeSurfer (see Methods), for N¼ 514
participants. Consistent with previous ﬁndings in healthy young
adults4,25, cortical thickness was negatively correlated with
age (r¼  0.27, P¼ 3.12 10 10).
Two out of 15 ICA methylomic patterns (termed ICA1 and ICA2)
were signiﬁcantly correlated with age, after Bonferroni correction
for 15 comparisons (ICA1: r¼ 0.54, Pnominal¼ 1.54 10 42,
Pcorrected¼ 2.31 10 41; ICA2: r¼ 0.29, Pnominal¼ 4.68 10 12,
Pcorrected¼ 7.02 10 11; Fig. 1c and Supplementary Table 2).
These methylomic patterns were also signiﬁcantly associated with
cortical thickness (ICA2: r¼  0.24, Pnominal¼ 3.86 10 8,
Pcorrected¼ 5.79 10 7; ICA1: r¼  0.14, Pnominal¼ 0.00162,
Pcorrected¼ 0.0243; Fig. 1b and Supplementary Table 2). No
signiﬁcant correlation was observed between ICA1 and ICA2
(r¼ 0.048; nominal P¼ 0.27), suggesting that the corresponding
independent components capture distinct methylomic processes.
To test whether the signiﬁcant correlations between ICA2 and
cortical thickness were merely attributable to the correlation
between age and both types of measurements, age effects were
partialled out from ICA2 and cortical thickness (see Methods).
After this adjustment, a signiﬁcant correlation was exclusively
detected between ICA2 and cortical thickness (r¼  0.18;
P¼ 6.55 10 5, Supplementary Table 2). The correlation
remained signiﬁcant (r¼  0.17; P¼ 8.74 10 5) also after
correcting for individual white blood cell count (see Methods).
We also examined which other available variables (that is, body
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mass index, smoking, alcohol consumption, frequency of
cannabis use) were signiﬁcantly associated with ICA2 in addition
to age. Smoking frequency was also signiﬁcantly associated with
ICA2 (r¼ 0.17, P¼ 0.0001) but not with cortical thickness
(r¼  0.072, P¼ 0.11). After adjusting ICA2 for both age and
smoking frequency, its association with cortical thickness
remained nearly unchanged (r¼  0.17). No signiﬁcant correla-
tions were detected between ICA2 and alcohol consumption
(P¼ 0.97), cannabis use (P¼ 0.1) or body mass index (P¼ 0.25).
In order to capture possible non-linear age effects, we also
performed an F-test analysis to compare the ﬁt of a model
predicting cortical thickness from a ﬁfth degree polynomial of age
(ageþ age^2þyþ age^5) to the ﬁt of the same model
augmented by ICA2. We observed a highly signiﬁcant increase
in adjusted R2 with the addition of ICA2 to the model
(F(1,507)¼ 15.6, P¼ 8.8 10 5). Thus, the association between
ICA2 and cortical thickness is not driven by non-linear age
effects.
We also used in silico annotation of blood cell types as
described by Jaffe and Irizarry26. After this adjustment, ICA2
associations with both chronological age and cortical thickness
remained highly signiﬁcant (P¼ 2 10 11 and P¼ 8.3 10 7,
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Figure 1 | ICA-based identiﬁcation of DNAm patterns. (a) Schematic representation of the analysis workﬂow; ICA decomposition of genome-wide
methylomic proﬁles (matrix X, n¼ 533 samples 397,947 CpGs sites) into k independent components, simultaneously represented across CpGs
(matrix S of CpGs loadings) and samples (matrix A of individual weights). A total of 15 components, whose corresponding weights represent global modes
of DNAm across samples, were tested for association with cortical thickness and chronological age. (b) Two components, ICA1 and ICA2, are signiﬁcantly
associated with cortical thickness. Horizontal axis: cortical thickness adjusted for sex, intra-cranial volume and MR-batches. Vertical axis: individual weights
on ICA component. (c) ICA1 and ICA2 show signiﬁcant association with chronological age. P: P value of association (Pearson’s correlation, two-sided test);
r2: fraction of variance in component weights explained by chronological age (in %).
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respectively). We also examined the association between ICA1
and ICA2 and chronological age in two publicly available data
sets of puriﬁed blood cells (N¼ 1,202 monocyte samples, age
range: 44–83, mean age: 60; N¼ 214 CD4þ T-cell samples,
age range: 45–79, mean age: 59)15. In each data set, ICA1 and
ICA2 were estimated as the linear combinations between ICA1
and ICA2 loadings, respectively (as inferred from the Swiss
DNAm sample), and blood samples’ DNAm values, adjusted
for main confounders (see Supplementary Methods). In both
cell-speciﬁc data sets, we observed a signiﬁcant positive
correlation between ICA patterns and chronological age
(monocyte samples, N¼ 1,202: ICA1: r¼ 0.67, Po2.2 10 16;
ICA2 r¼ 0.32, Po2.2 10 16; CD4þ T-cell samples, N¼ 214:
ICA1: r¼ 0.70, Po2.2 10 16; ICA2: r¼ 0.49; P¼ 8.6 10 15),
suggesting that the ICA–age correlations identiﬁed in
whole-blood are also detectable in individual cell types.
Altogether these results substantiate the lack of inﬂuence of
blood cell counts on the reported associations. The correlation
between cortical thickness and ICA1, that showed the strongest
correlation with age, was not signiﬁcant after adjusting for
chronological age (r¼ 0.01, P¼ 0.83, Supplementary Table 2).
In addition to chronological age, we also calculated epigenetic
cross-tissue- and whole-blood-based predictors in our sample as
described by Horvath27 and Hannum et al.14, respectively. Both
estimators yielded DNA methylation age values (that is,
predictors for chronological age based on CpG methylation)
that signiﬁcantly correlated with actual participants’ age
(Horvath’s predictor: r¼ 0.70, Po10 60; Hannum’s predictor:
r¼ 0.71, Po10 60). Neither predictor was associated with
cortical thickness after adjustment for chronological age
(Horvath’s: r¼ 0.04, P¼ 0.32; Hannum’s: r¼ 0.01, P¼ 0.77),
suggesting that these predictors (like ICA1 but, importantly,
unlike ICA2) do not mediate the effect of age on cortical
thickness.
Finally, we examined the association of ICA2 with age and
age-adjusted cortical thickness after covarying for 111 individuals
who contributed more than 10% to 111 inferred components
not further studied herein. Both associations remained
highly signiﬁcant (age: P¼ 4.91 10 12; age-adjusted cortical
thickness: P¼ 4.8 10 5).
Replication study. To test the generalizability of the association
between ICA2 and cortical thickness, we studied an independent
sample (termed herein the Munich sample) comprising
596 participants with major depressive disorder (MDD) and
healthy controls (see Methods). The ICA2 pattern was estimated
as the linear combination between ICA2 loadings (as inferred
from the Swiss DNAm sample) and individual DNAm values of
the Munich sample. In this independent sample, we observed a
signiﬁcant positive correlation between ICA2 and chronological
age (N¼ 596, r¼ 0.48, Po10 10) and a negative correlation with
global cortical thickness (N¼ 596, r¼  0.31, Po10 10). After
adjustment for chronological age and controlling for potential
confounders (diagnosis, sex, intracranial volume, MRI batch
effects, time difference between MRI examination and blood
drawing), the association between ICA2 and cortical thickness
remained signiﬁcant (r¼  0.094, P¼ 0.011). The same analysis
in a sub-sample of N¼ 163 participants younger than 40 years
(that is, within an age range similar to that of the Swiss partici-
pants) revealed an almost identical effect size (r¼  0.19,
P¼ 0.009) compared to that observed in the Swiss sample.
ICA2 partially mediates the age–cortical thickness relation.
ICA2 showed signiﬁcant positive correlation with age and
negative correlation with global cortical thickness. To investigate
whether ICA2 mediates the negative correlation between age and
global cortical thickness, we conducted a mediation analysis28.
The association between chronological age and global cortical
thickness was partially (that is, k2¼ 5.1% of the maximum
possible mediation effect) and signiﬁcantly mediated by the
methylomic pattern ICA2 (indirect effect¼  0.051, Po0.001)
(Fig. 2).
ICA2 is related to a speciﬁc pattern of cortical thickness.
Having detected an association between ICA2 and global
cortical thickness we next explored possible links between this
methylomic pattern and regional variations in cortical thickness.
Inter-individual variations in delineated brain regions often
coincide with latent structural covariance patterns29. Exploratory
factor analysis (EFA) allows depicting such distinct patterns
of volumetric covariance among brain regions that can be
subsequently tested for association with additional phenotypes
of the population under study30. We therefore performed
EFA, considering 68 regional brain measures of thickness
(34 per hemisphere) obtained from automated parcellation of
the cerebral cortex (Desikan-Killiany atlas)31–33. Before analysis,
effects of intra-cranial volume, sex, processing batches and age,
which possibly drive global correlations among brain regions,
were regressed out from individual measures (see Methods).
Using parallel analysis34, we determined eight extractable factors,
altogether accounting for 48.9% of variance across regional
measures (Supplementary Data 1, see Methods). Factor extraction
was followed by varimax orthogonal rotation. Subjects’ factor
scores were subsequently tested for association with the age-
adjusted ICA2 pattern. After correction for multiple testing, we
identiﬁed one factor score, F6, that showed signiﬁcant correlation
with ICA2 (r¼  0.13, P¼ 0.00314, Bonferroni-adjusted
P¼ 0.025 for eight tests conducted)(Fig. 3a and Supplementary
Table 3). This factor, accounting for 4% of variance in cortical
thickness measures, was characterized by a spatial pattern
comprising mainly temporal areas (loadings40.3), with the
highest loadings observed for left and right temporal poles and
Indirect effect:
–0.051 [–0.11; –0.01 ], P < 0.001
 Pb = 7.6×10–5
  rb = –0.17 
[–0.32;–0.03]
Pa = 1.5×10–11
ra = 0.29 
[0.15;0.43]
Age
Methylation pattern
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Global
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a b
c, c’
  Pc = 3.1×10–10, rc = –0.27 [–0.41;–0.13] 
 Pc’ = 5.7×10-7 , rc’ = –0.22  [–0.37;–0.08]  
k2= 0.051 [0.01;0.11]
Figure 2 | Mediation analysis of methylomic pattern ICA2 on the
association between chronological age and global cortical thickness. Path
a represents the effect of chronological age on ICA2. Path b represents the
effect of ICA2 on global cortical thickness after removing the effect of
chronological age. Path c denotes the total effect of chronological age
on global cortical thickness. Path c’ represents the direct effect of
chronological age on cortical thickness while controlling for the indirect
effect (a multiplied by b). r: correlation coefﬁcient; 99.9% conﬁdence
interval for the parameters are shown in brackets; P: P value of association.
k2: kappa-squared standardized maximum possible mediation effect.
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entorhinal cortices (mean loadings across the four temporal
regions: 0.58) (Fig. 4 and Supplementary Data 1). We also run
EFA under most conservative adjustment of the 68 regional brain
measures of thickness for mean global thickness, to study whether
the signiﬁcant regional effects observed herein are fully explained
by mean global cortical thickness. We observed high mean
correlation between factor loadings across the two EFA solutions
(r¼ 0.78); importantly, F6 remained stable across the two
solutions with an r¼ 0.89 (P¼ 6.9 10 24) between loadings
before/after adjustment for mean thickness. In addition, F6 scores
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Figure 3 | Correlations between ICA2 weights, EM performance and cortical thickness score F6. (a) Correlation between cortical thickness factor score
F6 and ICA2 weights in the methylomic proﬁling sample. (b) Correlation between ICA2 weights and EM performance in the methylomic proﬁling sample.
(c) Correlation between cortical thickness factor score F6 and EM performance in the combined sample (N¼ 1,234). Subjects from the methylomic
proﬁling sample are shown in blue. ICA2 and the EM/imaging phenotypes are adjusted for chronological age effects.
0.30
Left hemisphere Right hemisphere
0.37 0.44 0.51 0.59 0.66 0.73 0.80
Figure 4 | Regional cortical thickness loadings on factor F6 associated with ICA2 methylomic proﬁle. Absolute values for loadings are considered.
Loadingso|0.3| are not shown.
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obtained from the mean thickness-adjusted EFA solution were
still signiﬁcantly associated with ICA2 (r¼  0.09, P¼ 0.042),
suggesting that the results presented herein were not driven solely
by global mean thickness.
Thus, higher values of ICA2 are related to thinning of
a circumscribed cortical pattern that harbours neuroanatomical
correlates of episodic memory (EM). Therefore, we investigated
the relationship between this methylomic pattern and EM.
Behavioural assessment was obtained for a total of N¼ 531
subjects from the methylomic proﬁling study (see Methods,
Supplementary Table 1). We detected a signiﬁcant negative
correlation between ICA2 and EM performance (r¼  0.138,
P¼ 0.00147) (Supplementary Table 4). This association remained
signiﬁcant after partialling out age effects (r¼  0.122,
P¼ 0.00491) (Supplementary Table 4 and Fig. 3b) and after
adjustment for white blood cell types abundance (r¼  0.105,
P¼ 0.016 after adjusting for age).
Complete MRI and EM assessments were obtained for N¼ 512
participants from the methylomic proﬁling sample
(Supplementary Table 1). In this sample, the correlation between
F6 regional thickness score and EM performance was not
signiﬁcant (r¼ 0.048, P¼ 0.283)(Supplementary Table 5). In an
additional independent sample of N¼ 722 healthy young adults
(Basel imaging sample, Supplementary Table 1), who underwent
identical MRI (in the same scanner) and cognitive assessment
as the methylomic proﬁling sample (see Methods), the correlation
between F6 regional thickness score and EM performance was
signiﬁcant (r¼ 0.102, P¼ 0.00617)(Supplementary Table 5).
Importantly, subjects’ F6 factor scores from this additional
MRI sample were predicted based on the factor solution inferred
from the methylomic proﬁling sample. In the combined sample
(N¼ 1,234 participants), the correlation between F6 and
EM performance was signiﬁcant (r¼ 0.079, P¼ 0.00574)
(Fig. 3c and Supplementary Table 5).
Functional and genomic characterization of ICA2 CpGs.
Contributions to a given ICA component are commonly
identiﬁed by selecting features (here: CpG sites) whose loadings, in
absolute value, exceed a cut-off threshold of ns standard deviations
from the mean of the loadings’ distribution22. In gene expression
studies, such a typical threshold ranges between 2 and 3
(ref. 35). Given the pronounced multidimensionality of the
methylomic proﬁles, we used a stringent cut-off of ns¼ 4, which
led to the selection of 970 CpGs for ICA2 (Supplementary
Data 2). The selected ICA2 CpGs mapped to 593 genes
(see Methods). Among the 970 CpGs constituting ICA2, one
marker (cg18055007) was part of the 353 Horvath age-predicting
markers27, and four (cg20822990, cg16054275, cg16867657,
cg21139312) were part of the 71 CpGs included in Hannum’s
DNAm age model14. We also examined whether, and to what
extent, ICA2 CpGs (N¼ 970) overlapped with those reported as
being differentially methylated (N¼ 2,037) in smokers36–39. This
was the case for a small fraction (3%) of the ICA2 CpGs.
Enrichment analysis for gene ontology (GO) terms,
molecular pathways and gene expression patterns, as catalogued
in the Molecular Signatures Database (MsiGDB, www.broadin-
stitute.org/gsea/msigdb/index.jsp), was performed using the
GOseq algorithm40, which corrects for multiple CpG mapping
per gene (see Methods). Using an FDR thresholdo0.05
(Benjamini–Hochberg adjustment), analysis of ICA2 revealed
signiﬁcant enrichment for 76 highly overlapping gene sets,
which mainly encompassed genes related to immune system
function, inﬂammatory response and hematopoietic system
(Supplementary Data 3). To explore further the nature of the
immune component related to cortical thickness, we compared
the DNA methylation of the 970 most prominent ICA2 CpGs
to that of blood cell subtypes and their progenitors using
public data sets on 19 cell types (see Methods)41. We observed
consistently highly signiﬁcant correlations (N¼ 970 CpG sites,
Po10 60 for all correlations) between average whole-blood
DNAm values of the ICA2 CpGs and all various cell subtypes
examined (Supplementary Figs 3–5). The lowest correlation
coefﬁcients (albeit still highly signiﬁcant with Po10 60) were
observed for regulator and memory CD4þ T-cells
(Supplementary Fig. 5). Generally, the correlation coefﬁcients
might suggest high concordance of the cortical thickness-related
blood DNAm patterns with DNAm of B lymphocytes and
of the common myeloid progenitor lineage, and relatively
less concordance with DNAm of natural killer cells and
T lymphocytes.
We next characterized the ICA2-contributing CpGs with
respect to their topographical distribution across the
genome (that is, island, shore, shelf, open sea regions) and
to their relative location to gene transcripts. Given that a CpG
site may map to multiple transcripts, each site was uniquely
characterized according to following rules42: CpGs annotated
within 1,500 bp upstream the transcription start site of at least
one transcript were ﬂagged as ‘TSS’; CpGs not ﬂagged as ‘TSS’ but
located within a transcript (including 30UTR, 50UTR) were
ﬂagged as ‘Genic’; all remaining CpGs were ﬂagged as ‘Intergenic’.
We observed a signiﬁcant shift in the distribution of CpG
topographical categories as compared to the genome-wide
background expectations (w2 test P¼ 2.7 10 53) with 50% of
all CpGs annotated as Open Sea, while Islands CpGs were
clearly under-represented (10%)(Supplementary Fig. 1A). The
distribution of CpG sites across genomic context categories
differed from the genome-wide background distribution
(w2 test P¼ 1.65 10 6), with an increased fraction of ‘Genic’
CpGs and a decreased fraction of ‘TSS’ CpGs. We also observed
a lower fraction of intergenic CpGs as compared to the
background distribution (Supplementary Fig. 1B).
Finally, to test between-sample comparability of the identiﬁed
ICA patterns, we performed ICA of the study population
reported in Hannum et al.14, which consists of 656 blood
DNAm proﬁles of participants spanning a wide age-range
(19–101 years, mean age: 64 years). We identiﬁed ﬁve ICA
patterns that were signiﬁcantly associated with age (N¼ 656,
P¼ 0.000043 – Po10 60). We then examined the overlap
between ICA1 and ICA2 CpGs identiﬁed in our sample and
CpGs contributing to each of the Hannum age-associated
IC pattern. A signiﬁcant overlap with ICA1 was observed for
one pattern (termed here HICa, OR¼ 91, Po10 60). For ICA2,
we observed a signiﬁcant overlap with three age-associated
Hannum patterns (P¼ 1.9 10 6 – Po10 60), with said
overlap being particularly strong for one pattern (termed here
HICb, OR¼ 49, Po10 60). The correlation of loadings between
CpGs contributing to ICA2 and CpGs contributing to the HICb
pattern was positive and of substantial magnitude (r¼ 0.87,
Po10 60). Thus, we observed highly signiﬁcant between-sample
overlap of ICA patterns despite the differences in age structure
of the two populations.
ICA2-derived multigenic score associated with EM performance.
Given that DNA methylation patterns per se represent complex
traits18,43, we studied the genetic underpinnings of the ICA2
pattern. As for any genetically complex trait, several genetic variants
are likely to contribute jointly to inter-individual variability of
DNAm variation as represented by ICA2. Therefore, we employed
gene set enrichment analysis (GSEA)44–46 to disentangle
biologically meaningful subsets of genetic contributions to ICA2.
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DNA from all individuals participating in the methylomic
proﬁling study was processed on the Affymetrix Genome-wide
Human SNP Array 6.0. After standard QC, correction for
minor allele frequency and deviation from Hardy–Weinberg
equilibrium, a total of 733,370 autosomal SNPs were used for
association analysis (see Methods).
Age-adjusted single-marker P values for association with ICA2,
under an additive model, were tested for gene set enrichment
using MAGENTA44 (see Methods). Across the 1,411 tested sets
we detected a signiﬁcant over-representation of association
signals (FDRo0.05) in six gene sets mainly related to immune
system regulation (Table 1). Given the substantial overlap
between the identiﬁed gene sets, we further combined these sets
into two gene groups with minimum overlap: genes from
categories GO: Lymphocyte differentiation, GO: Leukocyte
differentiation and GO: Haemopoiesis were grouped into
GO:0048534 (Haemopoietic or lymphoid organ development)
which comprised 73 unique genes; the two remaining gene sets,
that contained 12 overlapping genes, Biocarta: Pyk2 pathway
and Biocarta: Keratinocyte pathway were grouped into
‘Pyk2/Keratinocyte pathway’, which comprised 60 unique genes.
These two distinct gene groups had one gene in common.
For each of the gene groups we calculated multilocus genetic
scores to capture their contributions to individual ICA2
variability. The scores comprised 39 and 33 signiﬁcant SNPs
mapping to an equal number of genes from the ‘GO:0048534’
and ‘Pyk2/Keratinocyte’ groups respectively (Supplementary
Data 4 and 5). Genetic scores were weighted by the direction of
effect of single-marker association statistics, resulting in positive
correlation of each score with the ICA2 pattern (see Methods).
As expected, both scores correlated signiﬁcantly with
ICA2 variability (‘GO:0048534’: r¼ 0.53, P¼ 3.26 10 40;
‘Pyk2/Keratinocyte’: r¼ 0.45, P¼ 5.9 10 28).
The genetic score derived from the Haemopoietic and
Lymphoid Organ development set (GO:0048534) was
signiﬁcantly correlated with EM performance (r¼  0.10,
P¼ 0.01). No signiﬁcant correlation was detected for the
‘Pyk2/Keratinocyte’-derived genetic score (r¼ 0.02, P¼ 0.7).
To test the robustness of this association, we studied
the correlation between the GO:0048534-derived genetic score
and EM in four additional independent samples (N¼ 3,346):
three samples, including subjects from the Basel imaging
sample, comprised a total of N¼ 2,603 healthy young
subjects who performed either a picture free recall or
a word free recall task; an additional sample included N¼ 743
elderly healthy individuals who performed a word free recall task
(age range: 74–91 years, see Methods and Table 2). The
genetic score correlated negatively with EM performance,
resulting in a signiﬁcant combined association P¼ 0.0003
(Stouffer Meta-analysis, Table 2).
To test whether GSEA-derived genetic score SNPs are enriched
for mQTLs of the ICA2 CpGs, we ﬁrst examined the location of
these SNPs relative to the 970 CpGs constituting ICA2. We
observed a signiﬁcant over-representation (53%, Po0.0002) of
gene score SNPs in cis (that is, ±1Mbp) to ICA2 CpGs as
compared to a genome-wide random distribution (see Methods).
Next, we performed mQTL analysis for each of the score
SNP–ICA2 CpG pairs. We observed signiﬁcant deviation from
the null uniform distribution with particular over-representation
of genetic associations with effect sizes ranging from small to
moderate (Supplementary Fig. 2). Thus, GSEA-derived SNPs
collectively exert multiple genetic effects of small to moderate
magnitude on the CpGs contributing to ICA2.
We also studied the association between the genetic score
and cortical thickness in the methylomic sample (N¼ 514).
No signiﬁcant correlation was observed with cortical thickness
(r¼  0.06, P¼ 0.08).
Discussion
In the present study we applied ICA decomposition of
whole-blood genome-wide methylomic proﬁles in healthy young
adults (22.9±3.3 years, mean±s.d.) and detected a speciﬁc
pattern of DNAm (ICA2) that was associated with cortical
thinning and decreased EM performance. We also observed that
a signiﬁcant part of the well-known negative correlation
between age and cortical thickness was partially mediated
by ICA2. CpG sites that contributed to this methylation
pattern mapped to genes involved in immune system regulation
and inﬂammatory response.
Notwithstanding the robust and replicated ﬁndings presented
herein, we would like to stress some limitations, which are
inherent to the study design. First, the mediation analysis
suggests that ICA2 signiﬁcantly, albeit partially, mediates the
effect of age on cortical thickness. Given the associative nature of
the data, we cannot exclude the possibility that the correlation
observed between ICA2 and cortical thickness might also be
partially driven by additional non-modelled variables. Second,
decomposition of genome-wide methylomic proﬁles comes at the
Table 1 | GSEA results for ICA2 pattern.
Database Gene set No. of genes* Nominal GSEA Pw FDR
Gene ontology Leukocyte differentiation 38 7.1 10 5 0.0124
Biocarta PYK2 pathway 27 6 104 0.0183
Gene ontology Lymphocyte differentiation 26 8.6 10 5 0.0234
Biocarta Keratinocyte pathway 44 2 104 0.024
Gene ontology Haemopoiesis 71 3.22 104 0.0407
Gene ontology Haemopoietic or lymphoid organ development 73 2 104 0.044
*Number of genes in gene set mapped by at least one SNP.
wEmpirical enrichment P value at a 75th percentile cut-off.
Table 2 | Association of Haemopoetic or Lymphoid Organ
development genetic score and EM-related traits in
independent samples.
Sample N Age range EM task r P
Basel cognitive 1,445 18–35 Pictures 0.062 0.00912
Basel imaging 534 18–35 Pictures 0.02 0.32
Zurich 624 18–45 Words 0.073 0.0349
AgeCode 743 74–91 Words 0.076 0.0191
Stouffer’s method meta-analysis 0.06* 0.0003
r: Pearson’s correlation coefﬁcient. P: one-sided correlation test P value.
*sample size weighted r.
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cost of speciﬁcity of the inferred solution towards the genomic
localization of CpG markers. The detection of CpGs contributing
to the methylomic signature relies on a ﬁxed threshold on the
distribution of the components’ loadings. In our case, this
approach allowed relating ICA2 broadly to genes involved in
immune system function. However, the speciﬁc relationships
between the identiﬁed marker sets and the phenotypes of interest
can be studied only in downstream experiments focusing on
single CpG sites. Third, the ICA model relies on the assumption
that methylomic signals arise from a ﬁxed set of independent
sources. In the absence of a priori knowledge about the
source signal, the number of inferred components must be
determined empirically, which might impact negatively on
generalizability. Integration of multiple-layers of molecular traits,
such as genotypic data used in this study, is therefore important
to address whether the identiﬁed patterns represent relevant
features of the data set.
The cellular mechanisms underlying changes in cortical
thickness are not entirely clear; however, they are most likely
life phase-dependent. During development, cortical thinning
might be related to events mirroring cortical maturation, such as
synaptic pruning47, whereas shrinkage of neurons, reductions of
synaptic spines and lower numbers of synapses probably account
for adult age-related cortical thinning48. In addition, myelination
of lower cortical layers might cause the cortical mantle to appear
thinner on MR scans49. This phenomenon might account for
a substantial part of the observed cortical thinning during
development. The correlation between cortical thickness and
cognitive function also seems to be age-dependent. In adulthood
and old age, cortical thinning is associated with a decline in
cognitive function3, whereas during development this
relationship is dynamic with predominantly negative correlation
between cognitive function and cortical thickness in early
childhood to a positive correlation in late childhood and
beyond6. Importantly, a substantial proportion of the strength
of the relation between cortical thinning and cognitive decline
in adults is attributable to the inﬂuence of age in each type
of measure3.
The association of ICA2 with cortical thickness and
EM performance reported herein supports observations relating
the peripheral immune system to brain morphology and
cognition50,51 and is coherent with the notion that the brain
and its functions is directly linked to peripheral tissues relevant to
the function of the immune system52. The data presented herein
might suggest high concordance of the cortical thickness-related
blood DNAm patterns with DNAm of B lymphocytes and
of the common myeloid progenitor lineage, and relatively
less concordance with DNAm of natural killer cells and
T lymphocytes. Nevertheless, it is important to stress that we
cannot draw any mechanistic conclusions about the relationship
between peripheral methylation on the one side and cortical
thickness and EM performance on the other, and that no further
inference can be drawn towards the contribution of a speciﬁc
immune cell type to the reported associations. Indeed, the
mechanisms through which the peripheral immune system exerts
an inﬂuence on the central nervous system remain elusive. Direct
cytokine-induced central responses or indirect cytokine-mediated
changes within the central nervous system via activation of
vagal-nerve afferents are being discussed among possible
scenarios53,54. Of note, methylation sites related to IL6R
(encoding interleukin 6 receptor), ZC3H12D (encoding zinc
ﬁnger CCCH-type containing 12D) and CD4 (encoding CD4
molecule) are listed among the top ten ICA2 contributing CpGs
(Supplementary Data 2) in our data. The products of these genes
are centrally implicated in cytokine signalling, mRNA stability of
cytokine genes and immunological response. It will be interesting
to investigate whether direct measurement of the immune factors
implicated herein along with traditional blood markers of the
immune system will provide additional information with regard
to the relation between these immune factors and cortical
thickness. We speculate that this might not be the case, given the
substantial volatility of such direct measurements, which mostly
reﬂect acute state of the immune system, whereas methylation
proﬁles reﬂect, at least partially, a record of past immune
regulation. Nevertheless, further experimental work is warranted
to test this hypothesis.
Inter-individual variability in blood cell composition is known
to inﬂuence whole-blood DNAm measurements55. In our
population of healthy young adults, no signiﬁcant association
between blood cell sub-types and cortical thickness or EM
performance was observed (Supplementary Table 6). Moreover,
the associations between ICA2, cortical thickness and EM were
signiﬁcant also after correction for blood cell composition. In
addition, we observed a signiﬁcant positive correlation between
ICA patterns (ICA1 and ICA2) and chronological age in the
examined blood cell-speciﬁc data sets. Thus, it is unlikely that the
detected associations are driven by inter-individual variability
in composition of blood cell types.
In addition to studying methylation patterns, we also
performed a genome-wide SNP-based analysis of ICA2. The
reasons for this analysis were two-fold: (1) Given the fact that
genetic variation is related to DNA methylation, we tested
whether ICA2-related genetic variation can be used as a proxy for
DNA methylation in larger samples, where such epigenetic
measures were unavailable. (2) We hypothesized that the
biological processes revealed through gene set enrichment
would be similar regardless of the nature of the data input
(that is, genetic versus epigenetic variation). Interestingly, the
SNP-based analysis of ICA2 revealed a robust association between
variants of genes involved in the regulation of the immune system
and EM in independent cohorts of young and elderly healthy
adults. This suggests that the association between ICA2,
which reﬂects epigenetic variation, and EM performance is, at
least partially, genetically driven.
In conclusion, we adopted an ICA approach to achieve
a tractable and biologically meaningful representation of
genome-wide methylation proﬁles that are amenable to
association testing. To this end we searched for methylomic
proﬁles that arise from putatively independent biological
processes, each reﬂected by a restricted number of CpG sites.
By decomposing genome-wide DNAm proﬁles we identiﬁed an
epigenetic mark of immune system genes linked to cortical
thickness and to human memory. The well-known effect of age
on cortical thinning is partially mediated by this epigenetic mark,
and its genetic underpinnings also point to genes involved in
immune system regulation. Thus, the decomposition of blood
methylome-wide patterns bears considerable potential for
the study of brain-related physiological traits. For example,
peripheral markers of systemic inﬂammation are associated with
reduced grey matter volume, both in midlife adults50 and in the
elderly56. Moreover, such grey matter reduction seems to mediate
the negative effects of peripheral inﬂammation on age-related
cognitive decline50. It will be interesting to investigate whether
the peripheral DNAm proﬁles identiﬁed herein might be used to
differentiate between physiological and pathological age-related
cognitive decline and cortical thinning.
Methods
Samples. Methylomic proﬁling sample. This sample is part of an ongoing,
continuously recruiting imaging genetics study of healthy young adults in the city
of Basel, Switzerland. Aim of the study is to recruit large samples of healthy young
adults for assessing cognitive performance measurements, personality traits,
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functional and anatomical MRI and genetics (based on saliva DNA) at the
time-point of the main investigation. Advertising for the main investigation was
done mainly in the University of Basel. Subjects were re-invited via email or at the
time-point of the main investigation to an additional blood and saliva sampling.
The time point of this second investigation was on average 348 days (min 1 day;
max 1,384 days; median 314 days) after the main investigation. For the purpose
of this study, a total of N¼ 568 subjects underwent blood methylomic proﬁling
(Data lock Apr. 2014). After pre-processing of methylomic data and genetic
outliers exclusion, a total of N¼ 533 subjects were included in the methylomic
proﬁling sample (Supplementary Table 1).
Basel imaging sample. This sample is part of the same ongoing, continuously
recruiting imaging genetics study as the methylomic proﬁling sample. A total of
N¼ 753 participants who were not part of the N¼ 533 methylomic proﬁling
sample underwent imaging and EM assessment. A total of N¼ 722 subjects with
complete imaging and EM assessment were included in the Basel imaging sample
(Supplementary Table 1), among which N¼ 623 subjects underwent genotyping.
Basel cognitive sample. This sample is part of an ongoing, continuously
recruiting genetics study in the city of Basel, Switzerland, independent from the
methylomic proﬁling and Basel imaging samples. A total of N¼ 1,622 healthy
young subjects underwent EM performance assessment and genotyping (mean age:
22.4; 66% female).
Zurich sample. This sample included a total of N¼ 706 healthy young subjects
recruited in Zurich, who underwent EM assessment and genotyping (mean age:
21.8; 70% female).
All participants were free of any neurological or psychiatric illness, and did not
take any medication at the time of the experiment (except hormonal
contraceptives). The ethics committee of the Cantons of Zurich, Basel-Stadt and
Basel-Landschaft approved the experiments. All participants received general
information about the study and gave their written informed consent for
participation.
AgeCode sample. This sample consisted of elderly participants of the German
Study on Ageing, Cognition and Dementia in primary care patients (AgeCoDe).
The AgeCoDe study is an ongoing primary care-based prospective longitudinal
study on early detection of mild cognitive impairment and dementia established by
the German Competence Network Dementia. The sampling frame and sample
selection process of the AgeCoDe study have been described in detail previously57
(see Supplementary Methods for complete description). Sufﬁcient DNA-samples
for genome-wide genotyping were available for 782 subjects. The complete
description of EM phenotypes can be found in Supplementary Methods. The
AgeCoDe-study was approved by the local ethic committees of all participating
centres (Ethics Committee of the Medical Association Hamburg; Ethics Committee
of the University of Bonn; Medical Ethics Committee II, University of Heidelberg
at the University Medical Center of Mannheim; Ethics Committee at the Medical
Center of the University of Leipzig; Ethics Committee of the Medical Faculty of the
Heinrich-Heine-University Du¨sseldorf; Ethics Committee of the TUM School of
Medicine, Munich). All participants received general information about the study
and gave their written informed consent for participation.
Munich sample. The Munich sample consisted of patients with ﬁrst episode and
recurrent unipolar depression treated as in-patients at the Max Planck Institute of
Psychiatry, Munich, and healthy control subjects (N¼ 627 with combined MRI
and DNA availability; 423 patients, age 47.9 (s.d. 13.8) years; control subjects age
49.5 (s.d. 13.3) years), for the most part overlapping with imaging genetic and
MDD association studies reported in collaboration with the ENIGMA
consortium58,59. Other than in the ﬂagship study58, no bipolar patients were
included for reasons of clinical homogeneity59. MDD diagnoses were based on
clinical consensus in addition to M-CIDI or SCAN interviews, depending
on the original study protocols. After pre-processing of methylomic data, and
MRI-QC-based exclusions, combined data of N¼ 596 subjects was available for
statistical analysis. Description of methylomic proﬁling and structural imaging of
the Munich sample are provided in Supplementary Methods. All participants gave
their written informed consent after receiving general information about the study.
Study protocols and the transition of anonymous data into the biobank of the Max
Planck Institute of Psychiatry were approved by the ethics committee of the Ludwig
Maximilian University in Munich, Germany.
Methylomic proﬁling. Blood samples were collected from all the subjects using
BD Vaccutainer Push Button blood collection set and 10.0ml BD Vacutainer Plus
plastic whole blood tube, BD Hemogard closure with spray-coated K2EDTA
(Becton, Dickinson and Company, New Jersey, USA). DNA was isolated from the
remaining fraction, upon plasma removal. The isolation was performed with
QIAmp Blood Maxi Kit (Qiagen AG, Hilden, Germany), using the recommended
spin protocol. Subject’s DNA was extracted between midday and evening
(mean time¼ 14:30, range 13:00–20.00). Microarray-based DNA methylomic
proﬁling from whole-blood samples was performed at ServiceXS (ServiceXS B.V.,
Leiden, the Netherlands). In brief, the bisulﬁte conversion was performed
with 500 ng genomic DNA input using the EZ DNA Methylation Gold Kit
(Zymo Research, Irvine, CA, USA). A bisulﬁte conversion quality control on the
samples was performed with DNA qPCR reaction and subsequent melting curve
analysis60. The bisulﬁte-converted DNA was processed and hybridized to the
HumanMethylation450 BeadChip (Illumina, Inc.), according to the manufacturer’s
instructions. Methylation data were pre-processed using the R package RnBeads61.
Beta values were calculated from SWAN normalized intensities62. Beta-values with
detection P valueZ0.05 were considered as missing. Individual probes were
excluded based on the following criteria: (1) non-CpG context probes, polymorphic
probes, probes harbouring three or more SNPs in their 50mer extension
(MAFZ0.01), and cross-hybridizing probes, based on the annotation provided
with the RnBeads package61, (2) cross-hybridizing probes and polymorphic
CpGs sites referenced in refs 63, 64, (3) detected by iterative Greedycut algorithm,
(4) missing rateZ5% in ﬁnal samples. After quality control a total of 397,947
autosomal probes remained for analysis. Samples showing divergent genetic
background from the majority of Caucasian samples were excluded; these genetic
outliers were identiﬁed using Bayesian Clustering Algorithm65 on genotypic
projections onto the two ﬁrst principal components inferred from reference
Hapmap populations (CEU, JPT, CHB). Exclusion of samples yielded a total
of 533 samples entering methylomic analyses.
To rule out systematic shift in DNA methylation values induced by SWAN
normalization, we compared the correlation between summary statistics of CpG
sites before and after normalization. We observed high correlation for both average
(r40.99) and variance (r40.95) of DNA methylation values across samples. We
also observed high average correlation between DNAm values before and after
normalization per-CpG site (average r¼ 0.87), and per-sample (average r¼ 0.89
after mean-centring DNAm values per CpG).
DNA methylation proﬁles were obtained on average 1 year after imaging
acquisition. We performed a sensitivity analysis examining the association between
ICA2 and cortical thickness after regressing out the difference (Dage) between age
at blood sampling and age at MRI assessment from the methylomic pattern. The
association remained signiﬁcant (P¼ 6.4 10 5, r¼  0.18 after adjustment for
age) indicating that Dage did not affect the results of the study.
Primary phenotypes (age, cortical thickness, EM performance) were not
confounded with methylomic processing covariates (plate, sentrix ID, position)
(linear model minimum observed P40.04).
ICA2 showed weak nominal association with Sentrix ID (Supplementary
Data 6). After adjustment of ICA2 for this technical covariate, the association
with age, cortical thickness and EM performance remained highly signiﬁcant
(age: P¼ 1.6 10 11; age-adjusted thickness: P¼ 1.3 10 4, EM: P¼ 0.0096).
Blood cell counting. Haematological analysis, including blood cell counts, was
performed at the collection time point with Sysmex pocH-100i Automated
Hematology Analyzer (Sysmex Co, Kobe, Japan).
Lymphocytes, neutrophils and overall count of basophils, monocytes and
eosinophils (mixture) were available for N¼ 527 participants from the methylomic
proﬁling sample.
Structural imaging. Participants from the methylomic and Basel imaging samples
underwent identical MRI assessment.
Measurements were performed on a Siemens Magnetom Verio 3T wholebody
MR unit equipped with a 12-channel head coil. A high-resolution T1-weighted
anatomical image was acquired using a magnetization prepared gradient echo
sequence (MPRAGE) sequence with the following parameter: TE (echo
time)¼ 3.37ms, FOV (ﬁeld of view)¼ 25.6 cm, acquisition
matrix¼ 256 256 176, voxel size¼ 1mm 1mm 1mm. Using a midsaggital
scout image, 176 contiguous axial slices were placed along the anterior posterior
commissure (ACPC) plane covering the entire brain with a TR¼ 2,000ms
(ﬂip angle¼ 8).
From the initial N¼ 533 participants from the methylomic proﬁling sample and
N¼ 753 from the Basel imaging sample, a total of 50 participants were excluded
due to excessive movement or scanner noise by visual inspection of T1-weighted
images, or technical reasons. This yielded a total of N¼ 514 from the methylomic
proﬁling sample entering structural imaging analysis, and N¼ 722 subjects from
the Basel imaging sample.
T1-weighted images were processed using the publicly available FreeSurfer
software (v4.5) (refs 31–33). This processing includes motion correction, removal
of nonbrain tissue, automated Talairach transformation, intensity correction,
volumetric segmentation, and cortical surface reconstruction and parcellation.
Speciﬁcally, the three-dimensional cortical surface was reconstructed to measure
volume, surface area and thickness at each surface location or vertex. After the
initial surface model was constructed, a reﬁnement procedure was applied to
obtain a triangulated representation of the grey/white (GM/WM) boundary. The
GM/WM boundary was then deformed outwards to obtain an explicit
representation of the pial surface. Thickness measurements were obtained by
calculating the distance between the GM/WM boundary and pial surfaces at each
vertex across the cortical mantle31. Global individual measures for thickness were
computed by averaging cortical vertices measurements for both hemispheres.
Individual measures were adjusted for sex, intra-cranial volume and MR-technical
batches (software and gradient batches) using linear regression.
ICA based identiﬁcation of methylomic patterns. After probes and samples
quality control, missing Beta values were imputed using the R package impute.
In order to adjust the methylation signals for technical confounders and preserve
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effects of chronological age on methylation sites, we applied the iteratively
re-weighted surrogate variable analysis algorithm implemented in the SVAR
package66, considering age at blood sampling as the outcome. Beta values were
adjusted for sex and 40 inferred surrogate variables using linear regression. For
each CpG, the residuals from this linear model were standardized across samples.
ICA decomposition of the standardized residuals was performed using the
R package fastICA. The number of components to extract was estimated using the
Random Matrix Theory algorithm67 implemented in the R package isva68. Given
the stochastic initialization of fastICA algorithm, we performed 30 repeats of the
ICA components’ estimation. All realizations of the mixing matrix (A) were
clustered using hierarchical clustering, with complete linkage agglomeration, based
on Pearson’s correlation similarity. Final components were determined as the
centrotypes of the inferred clusters.
When using such decomposition methods as ICA, multiple-correction depends
on the number of identiﬁed components, which in not known a priori. In our case,
the genome-wide methylomic data set was decomposed into 15 components
that were amenable to downstream association testing. Hence, traits correlated
with these 15 components were subjected to following a level adjustment:
P¼ 0.05/15¼ 0.0033. After having identiﬁed ICA2 as the only pattern associated
with cortical thickness, we further investigated its relationship with eight regional
thickness factor scores. The a level was thus adjusted for eight tests conducted
(P¼ 0.05/8¼ 0.00625).
Association testing of methylomic patterns. Swiss sample. The association
between ICA patterns and imaging or behavioural phenotypes was assessed using
Pearson’s correlation, with two-sided association test. Given the delta between
age at methylomic proﬁling and age at main investigation, chronological age
adjustment was achieved by partialling out age effects: effect of age at methylomic
proﬁling was regressed out from methylomic patterns and age at main
investigation was regressed out from the phenotypic measure, using linear
regression. Adjustment of methylomic patterns for blood cell counts was
performed by regressing out effects of chronological age at blood sampling and
effects of each of the three white-blood cell parameters using linear regression. The
obtained residuals were subsequently tested for association with the relevant
imaging or EM phenotypes.
Self-reported smoking frequency was measured on a 4-point Likert scale
(0¼ never, 1¼ occasionally, 2¼ 1–5 cigarettes per day, 3¼ 6–20 cigarettes per day,
4¼ 20 or more cigarettes per day). Self-reported alcohol consumption and
cannabis use frequencies were measured on a 3-point Likert scale (0¼ never,
1¼ occasionally, 2¼ daily). Association testing for each indicator was performed
using linear regression.
Munich sample. ICA2 patterns were calculated separately for the whole Munich
sample and a subsample ofo40-year-old subjects (N¼ 163). DNA methylation
values were ﬁrst adjusted for sex using linear regression. ICA2 patterns were then
calculated as linear combination between the scaled residuals and the inverse ICA2
loadings inferred from the Swiss sample (Supplementary Data 8). Separate Pearson’s
correlation analyses were performed between ICA2-scores and biographical age, and
ICA2-scores and cortical thickness. In addition, partial correlation analyses were
performed between ICA2-scores and cortical thickness, correcting for age at MRI,
difference between age at MRI and age at blood-drawing, sex, intracranial volume
and MRI batch effects. All P values reported in the replication sample are one-sided.
Exploratory factor analysis of cortical thickness measures. Average regional
cortical thickness in 68 areas (34 per hemisphere) were obtained from FreeSurfer
automated parcellation method based on Desikan-Atlas31–33. Individual measures in
each sample (methylomic proﬁling and Basel imaging samples) were adjusted for sex,
intra-cranial volume, MR-technical batches and chronological age using linear
regression. EFA was performed on regional cortical thickness measures from the
methylomic proﬁling sample (N¼ 514). Factor extraction was based on principal axis
factoring method. The number of factors to extract was determined using the parallel
method implemented in R package psych. The factor analysis solution was rotated
using the varimax method. A variable was considered to load on a factor if its
absolute loading on the factor was 0.3 or greater. Based on the factor solution inferred
from the methylomic proﬁling sample, we extracted factor scores predictions for both
the methylomic proﬁling sample and the independent Basel imaging sample, using
regression method. For each sample, factor scores were tested for association with
EM performance using Pearson’s correlation, with a two-sided association test. The
same association analysis was conducted combining factor scores and EM
performance of the two samples (combined sample, N¼ 1,234).
Mediation analysis. Chronological age at main investigation, ICA2 methylomic
pattern and global cortical thickness were entered in a mediation analysis28 using
the R package MBESS. To represent the strength of the mediation we computed the
indirect effect (a multiplied by b, see Fig. 1) and the k2 square value which is
interpreted as the proportion of the maximum possible indirect effect that could
have occurred69. The 99.9% conﬁdence intervals for these parameters were
obtained on bias-corrected and accelerated bootstrapping procedure with 10,000
resamplings. Signiﬁcance of the indirect effect was assessed by testing whether the
conﬁdence interval of the indirect effect excludes 0, considering interval limits from
90 to 99.9%.
Gene-set enrichment analysis of methylomic component. CpGs were mapped
to transcripts based on Illumina’s annotation; EntrezID gene identiﬁers were
downloaded from the UCSC genome database. Enrichment testing was performed
using the GOseq package40 which applies stringent correction towards genes
mapped by multiple CpGs across the array. Enrichment statistics were obtained
using Wallenius approximation. A total of 19,518 genes mapped by the 397,947
CpGs entering the analysis were used as background. Gene sets were downloaded
from the MSig DB (www.broadinstitute.org/gsea/msigdb/, curated gene lists
C2 and C5).
Genetic association analyses. Genotyping. DNA was extracted from saliva or
blood using standard protocols. All subjects were individually genotyped using the
Affymetrix Human SNP Assay 6.0 according to the manufacturer’s recommen-
dation. In the methylomic proﬁling sample, subjects with unusual ancestry
according to the majority of the sample were excluded using Bayesian clustering
algorithm and Hapmap reference populations (see Methylomic proﬁling). Subjects
were also checked for inconsistency between reported and genetically inferred sex.
Individual call rate averaged to 98.3%. For the purpose of scoring analyses, subjects
from the Basel imaging, Basel cognitive, Zurich and AgeCode samples were
additionally excluded based on the following criteria: genome-wide call rateo95%;
IBD sharing deﬁned by PI_HAT40.2 (one-sample of each detected pair was
excluded); Bayesian Clustering65 outlier detection on genome-wide call rate and
heterozygosity rate. This yielded a total of N¼ 1,445 individuals entering the
genetic scoring analysis for Basel cognitive sample, N¼ 534 for Basel imaging
sample, N¼ 624 for Zurich sample and N¼ 743 for AgeCode sample.
Validation of the link between methylation and genotype data. A per-subject
crosscheck between phenotypic data, methylation data and genetic data was
performed using the reported sex and sex-predictions based on the array data, as
well as matching of all SNPs represented on the Illumina 450 K array to the
corresponding Affymetrix SNP 6.0 genotype calls. This crosscheck allowed an
unambiguous assignment of each methylation data set to the corresponding genetic
and phenotypic data set.
Gene set enrichment analysis of ICA2 pattern. GSEA was performed using the
MAGENTA44 software which derives gene-centric association statistics from
single-SNP association P values, while controlling for potential confounders
(gene size, number of SNPs, number of independent SNPs, number of
recombination hotspots, linkage disequilibrium and genetic distance). Genome-
wide single-SNP association analysis was conducted on ICA2 pattern adjusted for
chronological age (at blood sampling), using an additive model. A total of 773,330
autosomal SNPs that passed individual SNP quality control in the methylomic
proﬁling sample (exclusion criteria MAFo0.01; HWE P valuer0.0001;
call-rateo0.90) entered the analysis.
In order to capture signals from potentially regulatory variants, MAGENTA-
derived gene scores were based on SNPs lying within 20 kb upstream and
downstream of the extreme transcript boundaries. The GSEA algorithm includes
a built-in procedure controlling for physical proximity of SNPs within a given gene
set (automatic exclusion of the gene exhibiting a lower association signal in case of
one SNP mapped to multiple genes within a gene set). Gene set enrichment statistic
was based on the 75th percentile cut-off of the observed genome-wide gene-score
distribution, which has been proposed to show optimal power for weak genetic
effects as expected for complex polygenetic traits. Empirical P values were adjusted
for multiple testing using FDR. Gene sets were extracted from the MSigDB v3.1
database (http://www.broadinstitute.org/gsea/msigdb), including gene sets from
different online databases (KEGG, Gene Ontology GO, BioCarta and Reactome).
We used a gene set size ranging between 20 and 200 genes to avoid both overly
narrow and broad gene set categories, resulting in 1,411 gene sets to be analysed.
Genes from the extended major histocompatibility complex region were excluded
from the analysis.
Genetic scoring association analyses. The scores comprised SNPs associated with
ICA2 pattern (Po0.05) mapping to an equal number of genes (that is, one most
signiﬁcant SNP per gene). Genetic scores were computed using the PLINK70 score
proﬁle procedure. Scores were weighted by the direction of effect of association
(þ 1 or  1) of each minor allele with ICA2 pattern inferred from the methylomic
proﬁling sample. Genetic score calculations were restricted to SNPs meeting the
inclusion criteria: MAFZ0.01; HWE P40.0001; call-rateZ90% within a sample.
Resulting genetic proﬁles were adjusted by regressing out the effect of the number
of missing SNPs per-subject included in the scoring procedure. Associations
between the inferred scores and behavioural or imaging phenotypes were assessed
using Pearson’s correlation. Given the negative correlation observed between ICA2
methylomic pattern and EM performance in the methylomic sample, genetic score
correlation tests with EM performance were one-sided (lower tail).
Description of additional analyses of ICA methylomic patterns can be found in
Supplementary Methods.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding authors on request.
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